The scientific community's quest to identify optimal targets for anticoagulant pharmacotherapy

Circulation. 2006 Nov 28;114(22):2313-6. doi: 10.1161/CIRCULATIONAHA.106.664169.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anticoagulants / therapeutic use*
  • Arthroplasty, Replacement, Hip*
  • Double-Blind Method
  • Factor Xa / drug effects
  • Factor Xa / metabolism*
  • Humans
  • Morpholines / therapeutic use*
  • Postoperative Period
  • Rivaroxaban
  • Thiophenes / therapeutic use*

Substances

  • Anticoagulants
  • Morpholines
  • Thiophenes
  • Rivaroxaban
  • Factor Xa